Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Global Contract Development and Manufacturing Organization (CDMO) Market: Competitor Landscape
In January 2023, Lottee Biologics, a CDMO company headquartered in South Korea, announced its investment plan of USD 3 billion to build three mega plants, each with a production capacity of 360,000 liters by 2030. The company is expected to begin commercial production by 2027, aiming to generate USD 3 billion in revenue by 2034 and bolster the biopharma ecosystem, thereby accelerating the discovery of new therapeutics. The rising trend of internal investments by prominent biopharmaceutical companies is anticipated to increase the contract development and manufacturing organization (CDMO) market size in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Catalant Inc.
- Baxter Biopharma Solutions (Baxter International Inc.)
- Vetter Pharma-Fertigung GmbH & Co. KG
- Recipharm AB
- Albany Moleculer Research Inc. (AMRI)
- Thermo Fisher Scientific
- Boehringer Ingelheim Group
- Pfizer Inc.
- NextPharma Technologies
- Jubilant Pharmova Ltd
- Famar SA
- Lonza Group
- TapeMark
- Novotech Pty Ltd
- ARX LLC
- Aenova Holding GmBH
- Tesa Labtec GmbH (TESA SE)
- CMIC Holdings Company Ltd
- Syneos Health Inc.
- LabCorp Drug Development
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Contract Development and Manufacturing Organization (CDMO) Market Report Snapshots
Contract Development and Manufacturing Organization (CDMO) Market Size
Contract Development and Manufacturing Organization (CDMO) Market Regional Analysis
Contract Development and Manufacturing Organization (CDMO) Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 225.58 billion in 2023, driven by the rising demand for novel drugs and therapies to treat chronic diseases across the globe.
The market is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032, likely to reach a market value of USD 489.99 billion by 2032.
The market demand is driven by the increase in the healthcare investments, disposable incomes, and the need for effective drugs to supplement the growth of the healthcare sector.
The increased mergers and acquisitions by prominent companies are one of the key market trends aiding the CDMO market growth. In January 2024, Kindeva Drug Delivery acquired Summit Biosciences Inc. to enhance its intranasal drug delivery capabilities.
The various services available in the market include active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, and secondary packaging services. Active pharmaceutical ingredient (API) manufacturing is further segmented into small molecule, large molecule, and high potency (HPAPI), whereas finished dosage formulation (FDF) development and manufacturing includes solid, liquid, and injectable dose formulation.
Based on the research phase CRO, the market is segmented into pre-clinical, phase I, phase II, phase III, and phase IV.
Based on the therapeutic area, the market is segmented into oncological, cardiovascular, and infectious diseases, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Key players involved in the market are Catalant Inc., Baxter Biopharma Solutions (Baxter International Inc.), Vetter Pharma-Fertigung GmbH & Co. KG, Recipharm AB, Albany Moleculer Research Inc. (AMRI), Thermo Fisher Scientific, Boehringer Ingelheim Group, Pfizer Inc., NextPharma Technologies, Jubilant Pharmova Ltd, Famar SA, Lonza Group, TapeMark, Novotech Pty Ltd, ARX LLC, Aenova Holding GmBH, Tesa Labtec GmbH (TESA SE), CMIC Holdings Company Ltd, Syneos Health Inc., and LabCorp Drug Development.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124